ArticleCancer medicine2023

Efficacy and safety of pyrotinib-containing regimen in the patients with HER2-positive metastatic breast cancer: A multicenter real-world study.

Sha Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.